Northern Trust’s Biora Therapeutics, Inc. Common Stock BIOR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-6,857
| Closed | -$34.4K | – | 4545 |
|
|
2024
Q3 | $34.4K | Hold |
6,857
| – | – | ﹤0.01% | 4270 |
|
|
2024
Q2 | $45.3K | Sell |
6,857
-5
| -0.1% | -$34 | ﹤0.01% | 4227 |
|
|
2024
Q1 | $75.5K | Buy |
6,862
+5,306
| +341% | +$57.4K | ﹤0.01% | 4149 |
|
|
2023
Q4 | $21K | Buy |
1,556
+425
| +38% | +$6.89K | ﹤0.01% | 4359 |
|
|
2023
Q3 | $24.5K | Hold |
1,131
| – | – | ﹤0.01% | 4301 |
|
|
2023
Q2 | $43.5K | Hold |
1,131
| – | – | ﹤0.01% | 4247 |
|
|
2023
Q1 | $31.3K | Buy |
1,131
+262
| +30% | +$8.88K | ﹤0.01% | 4369 |
|
|
2022
Q4 | $28.6K | Hold |
869
| – | – | ﹤0.01% | 4408 |
|
|
2022
Q3 | $105K | Buy |
869
+29
| +3% | +$5.22K | ﹤0.01% | 4099 |
|
|
2022
Q2 | $147K | Hold |
840
| – | – | ﹤0.01% | 4038 |
|
|
2022
Q1 | $244K | Hold |
840
| – | – | ﹤0.01% | 4050 |
|
|
2021
Q4 | $439K | Buy |
840
+694
| +475% | +$498K | ﹤0.01% | 3857 |
|
|
2021
Q3 | $56K | Hold |
146
| – | – | ﹤0.01% | 4518 |
|
|
2021
Q2 | $130K | Sell |
146
-655
| -82% | -$501K | ﹤0.01% | 4295 |
|
|
2021
Q1 | $954K | Buy |
801
+483
| +152% | +$666K | ﹤0.01% | 3604 |
|
|
2020
Q4 | $422K | Buy |
318
+98
| +45% | +$144K | ﹤0.01% | 3764 |
|
|
2020
Q3 | $497K | Buy |
+220
| New | +$498K | ﹤0.01% | 3608 |
|
Northern Trust's BIOR Position: Q4 2024 in Review
Northern Trust sold out of Biora Therapeutics, Inc. Common Stock (BIOR) in Q4 2024, closing a stake of 6,857 shares — an estimated $34.4K sold.
Northern Trust first reported a position in BIOR in Q3 2020 and held it in 17 quarters. The position peaked at $954K in Q1 2021. 0 funds tracked by Wall St. Rank hold BIOR as of Q4 2024.
- Northern Trust reported no remaining Biora Therapeutics, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
- Northern Trust sold 6,857 Biora Therapeutics, Inc. Common Stock shares in Q4 2024, an estimated $34.4K.
- Northern Trust first reported a position in Biora Therapeutics, Inc. Common Stock in Q3 2020 and held it in 17 quarters.
- Northern Trust's Biora Therapeutics, Inc. Common Stock position peaked at $954K in Q1 2021.
- 0 funds tracked by Wall St. Rank held Biora Therapeutics, Inc. Common Stock as of Q4 2024.
Based on Northern Trust's 13F filing for Q4 2024, filed 14 Feb 2025.